In-vivo Imaging Market Share

APAC Market Forecast

In-vivo imaging market in Asia Pacific is predicted to account for the largest share of 46% by 2036 impelled by the increasing spending in healthcare. This has led to the expansion of research & development activities in healthcare technology in the region, which might result in the development of more advanced In-vivo imaging techniques. According to estimates, the predicted cost of healthcare in India in 2020 was more than USD 190 billion.

North American Market Statistics

The North America In-vivo imaging market is estimated to be the second largest, during the forecast timeframe led by the presence of well-established healthcare infrastructure. The American economy's most important sector is the healthcare industry which focuses on cutting costs and enhancing patient outcomes. As a result, the availability of skilled medical professionals and advanced diagnostic techniques including for more precise diagnosis of diseases has increased in the region. This is expected to create huge demand for In-vivo imaging techniques.

Frequently Asked Questions (FAQ)

Increasing cases of cancer across the globe and the rising trend of precision medicine are the major factors driving the growth of the market.

The market size of In-vivo Imaging is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024 â€“ 2036.

The major players in the market are Bruker, FUJIFILM VisualSonics Inc., Siemens, Miltenyi Biotec, CMR Naviscan, SCANCO Medical AG, Aspect Imaging Ltd., Mediso Ltd., LI-COR, Inc., MILabs B.V., MR Solutions.

The Micro-MRI segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

In-vivo Imaging Market Share